Abstracts - faqs.org

Abstracts

Health

Search abstracts:
Abstracts » Health

There's a weight-loss drug, but it's no magic bullet

Article Abstract:

The Food and Drug Administration approved dexfenfluramine in Apr 1996 for use in a weight-reduction program that includes exercise and a low-calorie diet. The drug is not, however, one that will magically remove weight, according to the drug's proponents and its opponents, who question its safety and say its side effects are not yet known. Experts say that physicians may have to resist intense pressure from patients to prescribe the drug, but used judicially, its appetite-suppressing properties could be effective for many patients. It will be marketed as Redux in summer 1996 by Wyeth-Ayerst.

Author: Hearn, Wayne
Publisher: American Medical Association
Publication Name: American Medical News
Subject: Health
ISSN: 0001-1843
Year: 1996
Anorexigenics, Usage, Laws, regulations and rules, Pharmaceutical industry, Appetite depressants, Licensing agreements, United States. Food and Drug Administration, Dexfenfluramine, American Home Products Corp. Wyeth-Ayerst Laboratories Div., Weight reducing preparations, Anti-obesity agents

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Athletes breathe new life into nasal dilator market

Article Abstract:

The Breathe Right external nasal dilator is becoming a popular over-the-counter medical device among professional and college athletes as a way to open nasal passages. CNS Inc (Chanhassen, Minnesota) manufactures the Breathe Right product, which resembles an adhesive bandage. The product can decrease air-flow resistance by up to 31% and could benefit people with sinusitis, colds and allergies. A package of 12 Breathe Right units retails for $5, and each unit is effective for 12 hours. Fourth qtr 1994 earnings for the Breathe Right were $1.3 mil and earnings are expected to increase.

Author: Hearn, Wayne
Publisher: American Medical Association
Publication Name: American Medical News
Subject: Health
ISSN: 0001-1843
Year: 1995
Transdermal Drug Delivery Sys, Product information, Marketing, Transdermal drug delivery systems, Medical equipment and supplies industry, Medical equipment industry, CNS Inc. (Minneapolis, Minnesota), CNXS, Breathe Right Nasal Strips (Bandage)

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


New food supplement said to build strength - safely

Article Abstract:

A study conducted by the University of Iowa has shown beta-hydroxy beta- methylbutyrate (HMB) to cause the build-up of lean muscle tissue through strenuous exercise without the deleterious effects attached to other performance-enhancing substances such as anabolic steroids. Experts are asking that further testing of HMB be done to establish its safety, particularly if taken in large doses.

Author: Hearn, Wayne
Publisher: American Medical Association
Publication Name: American Medical News
Subject: Health
ISSN: 0001-1843
Year: 1996
Vitamin, Nutrient & Hematinic Preps, Physiological aspects, Dietary supplements

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA

Similar abstracts:
  • Abstracts: Uniforms do not spread infection. Speech problems threat to children's self-esteem. Child eczema needs holistic care
  • Abstracts: Experts fear 'get-tough' view of drug treatment may backfire. Help comes in many forms, from many different people
  • Abstracts: Becoming the middleman: direct contracting can be done, but it means taking on burdens your insurer once shouldered
  • Abstracts: Can plans manage the preventive care diabetics need? Medicaid misgivings. HMOs fear pay trouble under Ill. Medicaid managed care
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.